Washington Forum
April 25-27, 2022
Washington, DC
Last Updated: 19 April 2022*
* Update on Masking policy please see below
As AMS plans for the Washington Forum, we continue to monitor and keep track of the ongoing Covid situation. We are prioritizing the safety of presenters, attendees, program chairs, staff, and any volunteers who plan to attend in-person.
We are closely monitoring news and guidance from the Centers for Disease Control & Prevention (CDC), the World Health Organization (WHO), and local health agencies regarding travel and events.
We recommend that you check back here on any recommendations and guidance for our in-person event. This Commitment to Care will be adjusted as needed due to any updates and news regarding the impact of COVID-19, CDC guidance or emergence of new variants.
All attendees (presenters, program chairs, session chairs, exhibit booth staff, volunteers, attendees, guests, press, AMS staff) will be required to agree to the AMS Meeting Health and Safety Policy and Waiver before completing their registration. Any attendee who is not able to adhere to the in-person guidelines set forth in that Policy and Waiver, or in this Commitment to Care Statement, should plan to participate in the robust virtual options we are offering during this fully hybrid meeting.
Vaccination
It is our expectation that all in-person attendees at this meeting are up to date on their COVID-19 vaccinations as defined by the CDC. For international attendees, this guidance applies to COVID-19 vaccines authorized for emergency use by the World Health Organization. The full list of vaccines with final WHO EUL/PQ evaluation status is available here.
In-person attendees must provide proof of vaccination in the CLEAR app, before picking up their registration materials. Information on downloading and using the CLEAR app will be included in the registration confirmation email and informational emails sent prior to the meeting. If you are unable to access the CLEAR app, please contact [email protected].
Masking
At this time the AMS will be mandating masks for this meeting. Should this change we will post updates here.
Symptoms and Health Survey
In-person attendees who feel ill or experience any symptoms of COVID-19 before or during the meeting should not enter the AMS Meeting until the symptoms have resolved.
Testing
While we do not require that participants submit a negative Covid-19 test result in order to attend this meeting, all travelers should follow recommendations set for by the CDC for domestic and international travel as well as check requirements set forth by their travel providers (planes, buses, trains, and other forms of public transportation).
For local for Covid-19 testing, please visit this page to find the nearest location.